March 28, 2025

FDA Clears First OTC Multi-STI Test

The diagnostic test for chlamydia, gonorrhea, and trichomoniasis offers 30-minute results.

Conexiant

March 27, 2025

Trends in Spironolactone Prescribing Among Young Women

A cohort study of 38 million insured females aged 12 to 40 years found a marked increase in spironolactone prescriptions, most commonly for acne and other androgen-related conditions.

Conexiant

March 25, 2025

Does Bicalutamide Help Hair Loss?

A new randomized clinical trial found no added benefit from combining bicalutamide with minoxidil in the treatment of female pattern hair loss, contrasting with findings from previous retrospective studies and noting that further research on antiandrogen therapy is needed.

Conexiant

March 24, 2025

Monarez Tapped to Lead CDC

President Donald Trump nominates Susan Monarez as director of the CDC, track record and budget analysis provided.

Reuters

March 24, 2025

HS Guidelines for Special Populations

"These guidelines address the unique needs of diverse groups typically underrepresented in clinical trials, and highlight the importance of a multidisciplinary approach."

Conexiant

March 24, 2025

Study Finds No Clear Evidence That Red Wine Mitigates Cancer Risk

Investigators evaluated the anticancer properties of red wine compared to white wine.

The ASCO Post

March 21, 2025

Measles Tally Climbs in TX, NM

The CDC has said the measles, MMR vaccine is the most important tool for preventing measles.

Reuters

March 21, 2025

Biosimilars Match Adalimumab Originator Efficacy for Psoriasis

Amjevita and Imraldi were as effective as Humira for both new starters and patients switching from Humira, researchers concluded

Conexiant

March 20, 2025

Misconceptions Regarding Skin Cancer Risk in the United States

Investigators may have uncovered associations between the reported number of sunburns and sociodemographic characteristics as well as the prevalence of protective skin behaviors adopted by U.S. adults...

The ASCO Post